1. Helper T cell cytokine response to ribavirin priming before combined
treatment with interferon alpha and ribavirin for patients with chronic
hepatitis C.
Furusyo N, Kubo N, Toyoda K, Takeoka H, Nabeshima S, Murata M, Nakamuta M,
Hayashi J.
Antiviral Res. 67: 46-54, 2005. |
2. Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka Harasanshin Atherosclerosis Trial (FHAT).
Sawayama Y, Ariyama I, Hamada M, Otaguro S, Machi T, Taira Y, Hayashi J.
Atherosclerosis. 178: 303-9, 2005. |
3. Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production
by PBMC in adults after BCG vaccination.
Nabeshima S, Murata M, Yamaji K, Chong Y, Nomoto M, Hayashi J.
J Infect Chemother. 11: 18-23, 2005. |
4. Serum antibody response to tuberculosis-associated glycolipid antigen
after BCG vaccination in adults.
Nabeshima S, Murata M, Kashiwagi K, Fujita M, Furusyo N, Hayashi J.
J Infect Chemother. 11: 256-8, 2005. |
5. Pravastatin improves insulin resistance in dyslipsdemic patient.
Okada K, Maeda N, Kikuchi K, Tatsukawa M, Sawayama Y, Hayashi J.
J Atheroscler Thromb. 12: 322-329, 2005. |
6. Strenuous physical labor is important as a cause of elevated alanine
aminotransferase levels in Japanese patients with chronic hepatitis C viremia.
Kubo N, Furusyo N, Nakashima H, Kashiwagi K, Hayashi J.
Eur J Epidemiol. 20: 251-61, 2005. |
7. Efficacy of prolonged treatment following combination with ribavirin
and interferon for chronic hepatitis type C: A pilot study.
Nomura H, Kashiwagi Y, Nakashima H, Tanimoto H, Shimono J, Kajiwara E, Maruyama T, Yamashita N, Nagano M, Higashi M, Mukai T, Matsui Y, Hayashi J, Kashiwagi S, Ishibashi H.
Hepatol Res. 31: 211-6, 2005. |
|